GB872214A - Extraction process for the recovery of heparin - Google Patents
Extraction process for the recovery of heparinInfo
- Publication number
- GB872214A GB872214A GB24567/58A GB2456758A GB872214A GB 872214 A GB872214 A GB 872214A GB 24567/58 A GB24567/58 A GB 24567/58A GB 2456758 A GB2456758 A GB 2456758A GB 872214 A GB872214 A GB 872214A
- Authority
- GB
- United Kingdom
- Prior art keywords
- heparin
- salt
- protein
- precipitate
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Heparin is recovered by extracting defatted animal tissue with a salt solution maintained at a pH between 7 and 10 and of sufficient concentration to produce an anion concentration of between about one mole per litre of mixture and about saturation, and recovering heparin from the mixture. The preferred salt employed is sodium chloride at a concentration of at least about 60 gms. per litre, preferably 100 to 150 gms. per litre. Other salts specified are the alkali metal and ammonium citrates, halides, acetates, sulphates or thiocyanates or alkaline earth halides, acetates or citrates. The extraction temperature may vary from 0 DEG -100 DEG C., preferably 20 DEG -60 DEG C. Heparin may be recovered from the salt extract, after filtration, by acidification to a pH of less than 4 to precipitate the protein, separating the protein by centrifugation or filtration, and recovering the partially purified heparin from the filtrate by addition of an alcohol, acetone, or other water miscible organic solvent. When the soluble salt used in the extraction is not very soluble in the water-miscible solvent, it is desirable to subject the filtrate to dialysis before precipitating heparin or to dissolve the precipitated heparin in water, dialyse the solution and then reprecipitate the heparin. Heparin can also be recovered by acidifying the salt extract to precipitate the protein, separating the protein by filtration, and adding a fatty amine such as octylamine or dodecylamine to the filtrate to precipitate an amine-heparin salt. The heparin is recovered from the amine-heparin salt by reslurrying the salt in water with an alkali at a pH of about 10 to dissociate the salt, filtering, and adding alcohol or acetone to the filtrate to precipitate the heparin. A further method of recovering heparin from the salt extract comprises removing the salt from the original extract by dialysis, acidifying the dialysate to a pH of less than 4 to precipitate the heparin-protein complex, redissolving the complex in water at a pH between about 7 and 10, adding sufficient water soluble salt to the mixture to produce an anion concentration of between about one mole per litre of mixture, and about saturation, acidifying the mixture to a pH of less than 4 to precipitate the protein and separating the protein and recovering heparin from the remaining solution by adding methyl or ethyl alcohol or other water miscible organic solvent. Specification 754,885 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US872214XA | 1957-09-23 | 1957-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB872214A true GB872214A (en) | 1961-07-05 |
Family
ID=22203830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB24567/58A Expired GB872214A (en) | 1957-09-23 | 1958-07-30 | Extraction process for the recovery of heparin |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB872214A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4283530A (en) * | 1976-11-12 | 1981-08-11 | Schering Aktiengesellschaft | Process for the preparation of heparin |
FR2479834A1 (en) * | 1980-02-29 | 1981-10-09 | Italfarmaco Spa | PROCESS FOR PURIFYING GLUCOSAMINOGLUCANS |
US4315923A (en) * | 1979-03-21 | 1982-02-16 | Richter Gedeon Vegyeszeti Gyar Rt | Process for the production of organ extracts with high herparin content |
-
1958
- 1958-07-30 GB GB24567/58A patent/GB872214A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4283530A (en) * | 1976-11-12 | 1981-08-11 | Schering Aktiengesellschaft | Process for the preparation of heparin |
US4315923A (en) * | 1979-03-21 | 1982-02-16 | Richter Gedeon Vegyeszeti Gyar Rt | Process for the production of organ extracts with high herparin content |
FR2479834A1 (en) * | 1980-02-29 | 1981-10-09 | Italfarmaco Spa | PROCESS FOR PURIFYING GLUCOSAMINOGLUCANS |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1204048A (en) | Method for purifying native collagen | |
GB1274940A (en) | Isolation of proteins | |
GB872214A (en) | Extraction process for the recovery of heparin | |
US3936351A (en) | Method for preparing glucoronyl-glucosamino-glycan sulphates exhibiting antilipasaemic activity | |
US3497492A (en) | Preparation of placental albumin | |
JPS57130958A (en) | Recovery of l-phenylalanine and l-asparagic acid | |
GB979275A (en) | A method of preparing polypeptide substance having antiphlogistic properties | |
US2797184A (en) | Process for the recovery of heparin | |
GB1462442A (en) | Process for the recovery and purification of partricin | |
US2650242A (en) | Separation of tyrosine and cystine | |
GB1167469A (en) | Plasminogen Activator and Isolation Thereof | |
GB1280729A (en) | Process of recovering ammonium sulphate from an aqueous solution containing ammonium sulphate and methionine | |
FI960304A (en) | Method for precipitating natural avermectins | |
GB1480857A (en) | Production of protein isolates | |
US2596126A (en) | Method for separating diaryl-2-imino hydantoins from the corresponding 2,5-di-imino glycolurils | |
US2085768A (en) | Method of separating and isolating the thyreotropic and the gonadotropic hormone of the anterior lobe of the hypophysis | |
GB754885A (en) | Recovery of heparin | |
GB578590A (en) | Improvements in or relating to the preparation of penicillin salts | |
GB1214093A (en) | Purification of deoxycholic acid | |
US2907789A (en) | Process for the production of water-soluble anti-thrombotic organic salt preparations | |
GB906819A (en) | Parenteral solution for diagnostic test of cancer and a process of preparing same | |
GB1453063A (en) | Method for purifying 3,5-cyclic-adenylic acid or 3,5-cyclic- deoxy-adenylic acid | |
IL43608A (en) | Salts of amino-acids with polysulfuric esters of natural glycopeptides and process for preparing same | |
GB618174A (en) | Process for recovering proteolytic enzymes from the pancreas of mammals | |
GB647925A (en) | Improvements relating to the extraction and purification of an antibiotic |